Independent drug watchdog in Canada under funding threatBMJ 2008; 336 doi: http://dx.doi.org/10.1136/bmj.39598.708333.DB (Published 05 June 2008) Cite this as: BMJ 2008;336:1270
- Ray Moynihan, Melbourne
An internationally respected drug advisory body based at the University of British Columbia is facing closure after a report to the provincial minister for health called for its “replacement.”
The Therapeutics Initiative (www.ti.ubc.ca) produces evidence based reviews of drugs for doctors, policy makers, and the public, and the group has strict conflict of interest policies, which guarantee that its findings are as free of industry influence as possible.
A report from a task force of nine, submitted to the health minister of British Columbia last month, claims that although …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial